drugset / Trial / NCT06236022
The Effects of Sirolimus in Patients With Dilated Cardiomyopathy Infected With Kaposi Sarcoma-associated Virus
Phase 4
Recruiting
276 enrolled
Tongji Hospital
Wuhan Central Hospital · collabWuhan Fourth Hospital · collabWuhan University · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
Evaluating the efficacy of sirolimus (compared to standard therapy alone) in the treatment of dilated cardiomyopathy infected with Kaposi Sarcoma-associated virus -- a multicenter randomized controlled study.
Timeline
- Start
- 2024-01-01
- Primary completion
- 2028-12-31
- Completion
- 2028-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sirolimus | Small molecule | 2 mg | — |